Dendritične celice (DC), ki so jih leta 1973 sprva upodobili Ralph Steinman in Zanvil Cohn, imajo temeljno nalogo, da posegajo v notranje nevzdržne reakcije in spodbujajo prožen imunski odziv. Od tega trenutka so bili DC-ji obravnavani kot najintenzivnejše celice, ki prikazujejo antigen (APC), pogosto imenovane tudi "Naravni adjuvans", namenjene sprožanju lahkih in spominsko odpornih reakcij. Kar zadeva zaščito in upravljanje antigenov za vnos v celice T, imajo DC-ji prevladujočo mejo in izražajo nenormalne količine kostimulatornih ali kohibitornih atomov, ki določajo varen začetek ali anergijo1. Že približno 40 let po tem, ko je leta 2011 Ralphu Steinmanu podelila Nobelovo nagrado za medicino ali fiziologijo za razkritje teh bistvenih naravnih imunskih celic, je bil zaznan pomen DC-jev.
Ta imunoterapija treatment helps the body battle cancer cells with its own defense mechanism. Dendritic cell therapy is often used when regular therapies have not been effective. As of late, this treatment was proposed in India and multiple patients were relieved under the supervision of the renowned Oncologist with empowering results. Be that as it may, there are common drugs that have been developed over decades for most forms of tumor. Usage of these drugs is administered and combined with unsusceptible care, since it is realized that tumor cells weakened by chemotherapy or radiation are considerably easier to decimate with invulnerable cells than with flawless tumor cells.
Vrsta raka, zdravljena z imunoterapijo na osnovi dendritičnih celic
- Kožni rak
- Rak ledvic
- Rak na dojki
- Rak trebušne slinavke
- Rak debelega črevesa
- Rak jajčnikov
- Prostratni rak
IV. Stopnja zdravljenja raka
Dendritic cell based immunotherapy treatment has proved to be quite a success specially with no hope stage IV cancer treatment. Patients specially on stage IV cancer can try and go for dendritic cell based immunotherapy in cancer treatment.
Bolnišnice za zdravljenje imunoterapije na osnovi dendritičnih celic v Indiji
- LDG India Ltd, Gurugram
- APAC Biotech, Noida
- Raziskave dendritičnih celic, New Delhi
Stroški zdravljenja z imunoterapijo na osnovi dendritičnih celic v Indiji
Stroški zdravljenja z imunoterapijo na osnovi dendritičnih celic se lahko razlikujejo 8000 USD - 15,000 USD odvisno od stopnje raka in lečečega zdravnika ter bolnišnice.
